Ortho-McNeil Pharmaceuticals

Ortho-McNeil Pharmaceuticals was a prominent American pharmaceutical company and a subsidiary of Johnson & Johnson, headquartered in Raritan, New Jersey. The entity was established in 1993 following the merger of Ortho Pharmaceutical and McNeil Pharmaceutical, two established Johnson & Johnson units. The company focused on diverse therapeutic areas, including central nervous system disorders, infectious diseases, women's health, and urology. Its commercial portfolio included well-known brands such as the antibiotic Levaquin, the anticonvulsant Topamax, and the ADHD medication Concerta. In 2011, Johnson & Johnson reorganized its pharmaceutical segment, integrating Ortho-McNeil into Janssen Pharmaceuticals to streamline its global operations.